This article compares Amazon (AMZN) and Alphabet (GOOG), focusing on their Q2 2026 performance and AI infrastructure investments. While both tech giants show significant growth in cloud services, the author argues that Alphabet presents a more favorable investment due to its valuation, higher operating margins, and superior stock performance over the past year. The piece highlights Alphabet's strategic bets on AI through Gemini and Waymo, despite increased debt, and concludes by favoring Alphabet over Amazon.

Canaccord has reiterated a Hold rating and an $85 price target for Edwards Lifesciences (NYSE:EW) after Medicare finalized coverage for transcatheter aortic valve replacement (TAVR) procedures, including those for asymptomatic severe aortic stenosis. Despite the stock trading above Canaccord's target at $86.77 and a premium valuation, 15 analysts have revised earnings downwards for the upcoming period, adding a cautious note to the Hold rating. The finalized Medicare policy is expected to be a long-term tailwind for TAVR due to formalized coverage, removal of facility volume thresholds, and increased workflow flexibility.

BofA Securities has adjusted its price target for Packaging Corp. of America (PKG) to $260 from $280, while maintaining a Buy rating on the stock. This update reflects a revised valuation perspective for the paper packaging manufacturer. The article also provides recent news and financial data for Packaging Corp. of America, including dividend information and analyst ratings.

KeyBanc has initiated coverage on Sherwin-Williams Co. (NYSE:SHW) with a Sector Weight rating and a price target of $365.00, acknowledging the stock's elevated multiples due to its strong U.S. architectural franchise despite a currently depressed housing market. The firm notes the company's strong market share in North America paint stores at approximately 40%, which may make further share gains challenging. Other analysts like Morgan Stanley and DA Davidson have also recently updated their price targets, indicating a positive outlook on the company's potential for accelerated earnings.

The Manufacturers Life Insurance Company has reduced its stake in Lowe's Companies Inc. by 3.8%, selling 49,223 shares but still retaining a significant holding of 1.23 million shares valued at approximately $271.4 million. Despite this reduction, institutional investors collectively own 74.06% of the company, and analysts generally maintain a "Moderate Buy" rating with an average price target of $257.63. Lowe's also reported strong Q2 earnings, beating EPS estimates, and announced a quarterly dividend of $1.25 per share.

KeyBanc has initiated coverage on Eastman Chemical Co. (NYSE:EMN) with a Sector Weight rating and a $75 price target. The firm views Eastman Chemical as a stable company within its chemical group due to its earnings stability, cash flow, and balance sheet strength, expecting future earnings to benefit from improved industrial demand and specific company drivers. Despite this, KeyBanc sees better risk-reward opportunities in other chemical companies, noting Eastman Chemical's current valuation is reasonable, while Moody's recently adjusted the company's outlook to negative due to lower-than-expected operating cash flow projections.

KeyBanc initiated coverage on Corteva (NYSE:CTVA) with a Sector Weight rating and a $92 price target, expressing concerns about the strategic rationale of its upcoming spin-off into new Corteva and Vylor. Despite recognizing Corteva's strong fundamentals and consistent dividend increases, KeyBanc anticipates increased competition in the seed business and will wait for the spin-off before considering a more attractive entry point. This initiation comes amidst other analyst ratings and a recent $455 million PFAS settlement involving Corteva.

KeyCorp analysts project Corteva (NYSE:CTVA) to report a Q3 2026 loss of $0.33 per share, followed by $0.31 EPS in Q4, and full-year earnings of $4.00 for fiscal 2027 and $4.20 for fiscal 2028. Despite a recent revenue miss, Corteva exceeded EPS expectations in its last quarter and reaffirmed its 2026 EPS guidance. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $91.50, suggesting a favorable outlook for the agricultural science company.

KeyBanc has initiated coverage on Linde (NASDAQ:LIN) with an overweight rating and a $542.00 price target, citing the company's high quality, impressive dividend track record, and emerging tailwinds in its end markets, particularly from industrial demand acceleration and increased investments in electronics and semiconductors. While acknowledging the valuation is not inexpensive, the firm believes it is justified given Linde's market position and growth prospects. Other analysts like UBS and Bernstein also maintain positive outlooks, despite some concerns about Linde's Lincare healthcare business.

Tidal Investments LLC significantly increased its stake in Valmont Industries (NYSE: VMI) by 33.6% in the second quarter, now owning 34,510 shares valued at $19.9 million. This move comes as institutional investors hold 87.84% of the company, which recently reported strong quarterly earnings, beating EPS estimates and seeing a 6.5% revenue increase. Analysts maintain a "Moderate Buy" rating for VMI with an average price target of $587, despite mixed insider activity.